<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04567056</url>
  </required_header>
  <id_info>
    <org_study_id>N-20190047-2</org_study_id>
    <nct_id>NCT04567056</nct_id>
  </id_info>
  <brief_title>Specific Methylation Profiles in HNSCC</brief_title>
  <official_title>Validation of Specific Methylation Profiles Ind Head and Neck Cancer - A Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aalborg University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aalborg University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the study, N-20190047, the investigators aim to define specific methylation patterns in a&#xD;
      group of patients with head and neck squamous cell carcinomas.&#xD;
&#xD;
      With this study the investigators aim to validate these findings in a larger cohort.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 16, 2020</start_date>
  <completion_date type="Anticipated">December 20, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic accuracy</measure>
    <time_frame>At diagnosis</time_frame>
    <description>How accurate can the methylation profiles diagnose the head and neck squamous cell carcinoma</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Head and Neck Squamous Cell Carcinoma</condition>
  <arm_group>
    <arm_group_label>Cancer group</arm_group_label>
    <description>Patients with verified head and neck squamous cell carcinomas</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>Matched control group without active or earlier cancer and a normal ENT examination.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Blood sample</intervention_name>
    <description>A separate blood sample will be taken for methylation-analyses</description>
    <arm_group_label>Cancer group</arm_group_label>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Peripheral blood samples&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Cancer group:&#xD;
&#xD;
        Patients referred from the region of Northern Denmark to the Department of&#xD;
        Otorhinolaryngology - Head and Neck Surgery with suspicion of, or with already verified&#xD;
        Head and neck squamous cell carcinoma. Only patients with verified squamous cell carcinoma&#xD;
        after diagnostic work-up will be eligible.&#xD;
&#xD;
        Control group:&#xD;
&#xD;
        Patients referred from the region of Northern Denmark to the Department of&#xD;
        Otorhinolaryngology - Head and Neck Surgery for evaluation or treatment, but without&#xD;
        suspected or verified malignancy of the head and neck.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Cancer group:&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
          -  Verified head and neck squamous cell carcinoma&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Other active cancer&#xD;
&#xD;
          -  Uncontrolled comorbidity&#xD;
&#xD;
          -  Unable to give informed consent&#xD;
&#xD;
        Control group:&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
          -  Normal ENT-examination&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Other active cancer&#xD;
&#xD;
          -  Uncontrolled comorbidity&#xD;
&#xD;
          -  Unable to give informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Gaihede, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Otolaryngology - Head and Neck Surgery, Aalborg University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christian Danstrup, M.D.</last_name>
    <phone>+45 23800598</phone>
    <email>csd@rn.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michael Gaihede, Professor</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Otolaryngology - Head and Neck Surgery</name>
      <address>
        <city>Aalborg</city>
        <zip>9000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Danstrup, M.D</last_name>
      <phone>+45 23800598</phone>
      <email>csd@rn.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>September 23, 2020</study_first_submitted>
  <study_first_submitted_qc>September 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 28, 2020</study_first_posted>
  <last_update_submitted>July 20, 2021</last_update_submitted>
  <last_update_submitted_qc>July 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aalborg University Hospital</investigator_affiliation>
    <investigator_full_name>Christian Sander Danstrup</investigator_full_name>
    <investigator_title>Associate Professor, M.D.</investigator_title>
  </responsible_party>
  <keyword>Head and neck cancer</keyword>
  <keyword>Squamous Cell carcinoma</keyword>
  <keyword>Methylation</keyword>
  <keyword>DNA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma, Squamous Cell</mesh_term>
    <mesh_term>Squamous Cell Carcinoma of Head and Neck</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

